Measuring Rigidity During Deep Brain Stimulation Surgery: Evidence of Clinical Benefits in Patients With Advanced Idiopathic Parkinson's Disease

深部脑刺激手术期间测量肌肉僵硬程度:晚期特发性帕金森病患者临床获益的证据

阅读:2

Abstract

INTRODUCTION: Wrist rigidity, conventionally qualitatively assessed by clinicians, is an important feature for the success of the deep brain stimulation of subthalamic nucleus (STN-DBS) surgery in patients with Parkinson's disease (PD). To tackle this subjectivity, our group designed and implemented a wearable device with an embedded sensor, the iHandU system (inSignals Neurotech), to quantify the rigidity in real time, supporting the clinical decision-making during STN-DBS. METHODOLOGY:  This study aimed to evaluate the clinical benefit of using the iHandU device for real-time rigidity quantification during STN-DBS surgery in patients with advanced idiopathic PD. For this purpose, we conducted a retrospective cohort study involving 81 patients with advanced PD undergoing STN-DBS in Movement Diseases and Functional Surgery Unit of the Centro Hospitalar e Universitário São João, Porto, Portugal,, comparing 40 patients assessed intraoperatively with the iHandU device to 41 patients assessed by manual methods. Clinical outcomes (motor scores, stimulation parameters, and medication dosage) were compared at multiple time points over a 12-month follow-up. RESULTS: We found that the iHandU group showed significantly higher improvement in motor symptoms with reduced ON/OFF fluctuations and dyskinesias. These gains were obtained with less stimulation current, which reduced the occurrence of side effects, such as speech impairment. Moreover, the iHandU group did not show any significantly worse parameters, although sleep disturbances were more frequent (but not statistically significant) than in the control group. CONCLUSIONS: The use of iHandU device during STN-DBS was associated with better clinical benefits, namely, by providing improved motor benefits, fewer dyskinesias, and fewer cases of speech disturbance, among other less significant benefits. The use of PD symptom measurement instead of qualitative assessment is probably associated with better clinical outcomes and should be used more frequently in symptom evaluation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。